Chemiluminescent Reagents for Diagnosis Using the Digene Hybrid Capture (hc2) Method

Chemiluminescent Reagents for Diagnosis Using the Digene Hybrid Capture (hc2) Method

Chemiluminescent reagents for the Digene Hybrid Capture (hc2) method are designed to provide accurate and reliable diagnostics for various infections, including HPV (Human Papillomavirus), chlamydia, and gonorrhea. These kits and devices ensure high efficiency and precision of results.

Available Kits and Equipment:

• hc2 HPV DNA Test – for detecting both high-risk and low-risk HPV types
• hc2 High-Risk HPV DNA Test – for detecting high-risk HPV types
• hc2 HPV Genotyping PS Test – for high-risk HPV detection with genotyping
• hc2 Training Panel – training panel for laboratory use
• DNAPAP Cervical Sampler – kit for collecting cervical samples
• Female Swab Specimen Collection Kit – cervical sample collection kit for pregnant women
• hc2 CT/GC DNA Test – for detection of chlamydia and gonorrhea infections
• hc2 GC-ID DNA Test – for detection of gonorrhea infection
• hc2 CT-ID DNA Test – for detection of chlamydia infection
• Sample Conversion Kit – kit for sample preparation

These chemiluminescent diagnostic reagents are a reliable tool for laboratories, ensuring fast and accurate results in the detection of infectious diseases.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Chemiluminescent Reagents for Diagnosis Using the Digene Hybrid Capture (hc2) Method, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.